Use and properties of ROCK-specific inhibitor Y-27632.
Narumiya
S
S
Department of Pharmacology, Kyoto University Faculty of Medicine, Japan.
Ishizaki
T
T
Uehata
M
M
D016475:3T3 Cells; D000255:Adenosine Triphosphate / Q000378:metabolism; D000577:Amides / Q000494:pharmacology*; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology*; D001667:Binding, Competitive; D048429:Cell Size / Q000187:drug effects; D004791:Enzyme Inhibitors / Q000494:pharmacology; D022001:Focal Adhesions / Q000187:drug effects; D047908:Intracellular Signaling Peptides and Proteins; D051379:Mice; D009119:Muscle Contraction / Q000187:drug effects; D009125:Muscle Relaxants, Central / Q000494:pharmacology*; D009130:Muscle, Smooth / Q000187:drug effects; D016501:Neurites / Q000187:drug effects; D017346:Protein Serine-Threonine Kinases / Q000037:antagonists & inhibitors*; D011725:Pyridines / Q000494:pharmacology*; D022502:Stress Fibers / Q000187:drug effects; D054460:rho-Associated Kinases
D000577:Amides; D000959:Antihypertensive Agents; D004791:Enzyme Inhibitors; D047908:Intracellular Signaling Peptides and Proteins; D009125:Muscle Relaxants, Central; D011725:Pyridines; C108830:Y 27632; D000255:Adenosine Triphosphate; D017346:Protein Serine-Threonine Kinases; D054460:rho-Associated Kinases